Brandon Dionne
bwdionne.bsky.social
Brandon Dionne
@bwdionne.bsky.social
Associate Clinical Professor at Northeastern University School of Pharmacy and Pharmaceutical Sciences

Infectious Diseases Clinical Pharmacist at Brigham and Women's Hospital.

He/him.
Reposted by Brandon Dionne
I applaud workers at the CDC for standing up against Sec. Kennedy’s dangerous anti-vaccine crusade.

We are witnessing a full-blown war on public health from the Trump Administration.

History will not look kindly on those who stayed silent in the face of this assault on science.
August 28, 2025 at 10:34 PM
Reposted by Brandon Dionne
The federal HIV guidelines face a shutdown.
A trusted, living resource -- used by clinicians, programs, and public health agencies for decades -- may disappear due to “budget decreases and revised priorities.”
Big mistake. #IDSky blogs.jwatch.org/hiv-id-obser...
Federal HIV Guidelines Face a Shutdown — A Critical Loss for Clinicians and Patients
Each week, our HIV clinical group gathers to review active patients, share updates, and celebrate good news. On our whiteboard, we list four columns: Inpatients, Outpatients, Issues, and Celebrations....
blogs.jwatch.org
June 20, 2025 at 6:23 PM
Reposted by Brandon Dionne
Happy ID pharmacist's Day! Thanks for joining us for our chat today to celebrate and spread the word about ID pharmacists. Don't forget to tag us and follow your fellow ID pharmacists :)

Q1. Please introduce yourself and tell us why you love being an ID pharmacist!
May 22, 2025 at 4:05 PM
Reposted by Brandon Dionne
Makary and Prasad have a sounding board piece written in NEJM about the future of COVID-19 vaccine regulation at the FDA.

Some thoughts:
An Evidence-Based Approach to Covid-19 Vaccination | NEJM
This article from the FDA compares broad U.S. recommendations on Covid vaccination with those from other countries and announces the adoption of an evidence-based approach to such recommendations.
www.nejm.org
May 20, 2025 at 4:18 PM
I'm proud to share that I was recognized as a Fellow of the Infectious Diseases Society of America! @idsainfo.bsky.social
May 20, 2025 at 2:23 PM
Reposted by Brandon Dionne
‼️The @idsainfo.bsky.social cUTI guideline 📄 draft is now available for public comment🗣️! This version has been reviewed by 15+ orgs & revised according to extensive feedback provided to us. www.idsociety.org/practice-gui...

UTIsky IDsky Medsky PharmSky
February 20, 2025 at 12:18 AM
Reposted by Brandon Dionne
WHERE WAS THIS 6 MONTHS AGO WHEN I WAS RESEARCHING OUR TETRACYCLINES EPISODE??!!

Wotevs. Check out this awesome review

Unless u r driving or hate reading; then our episode is here: podcasts.apple.com/gb/podcast/i...

And the episode on the newer agents here: podcasts.apple.com/gb/podcast/i...
January 14, 2025 at 6:29 PM
Reposted by Brandon Dionne
Tetracyclines always been a fascinating antibiotic class. So many different evolutions, and antimicrobial activity that variably spans across Gram pos & neg bacteria, as well as malaria!

Cool review in @cmicomms.bsky.social by @jeffpears0n.bsky.social @bwdionne.bsky.social

#IDSky #clinmicro #AMR
Tetracyclines, the Old and the New: a Narrative Review
Tetracyclines have remained a cornerstone of antimicrobial therapy for over seven decades, demonstrating broad-spectrum activity against a wide range …
www.sciencedirect.com
January 14, 2025 at 12:23 PM